ZBH — Zimmer Biomet Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapNeutral

Annual income statement for Zimmer Biomet Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	8-K
Standards:	USG	USG	USG	USG	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	6,827	6,940	7,394	7,679	8,232
Cost of Revenue
Gross Profit	4,867	4,920	5,310	5,487	5,738
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	6,132	6,244	6,117	6,393	7,133
Operating Profit	695	696	1,278	1,286	1,098
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	499	404	1,067	1,037	831
Provision for Income Taxes
Net Income After Taxes	446	291	1,025	905	705
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	402	231	1,024	904	705
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	402	231	1,024	904	705
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.66	3.2	5.78	5.6	4.69
Dividends per Share